Effects of deletion-type human hepatocyte growth factor on murine septic model

Journal of Surgical Research

Volumn 85, Issue 1, 1999, Pages 88-95

  Kondo, Hiroyuki ^a   Tani, Tohru ^a   Kodama, Masashi ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

dHGF; Liver injury; Multiple organ failure; Thrombomodulin

Indexed keywords

SCATTER FACTOR; THROMBOMODULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; INTRAVENOUS DRUG ADMINISTRATION; LIVER INJURY; LIVER PROTECTION; LIVER REGENERATION; LIVER SINUSOID; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RAT; SEPSIS; TISSUE REPAIR;

EID: 0032775708     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.1999.5643     Document Type: Article

References (29)

1. Muto Y., Nouri, Aria K. T., Meager A., Alexander G. J., Eddleston A. L., Williams R. Enhanced tumor necrosis factor and interleukin-1 in fulminant hepatic failure. Lancet. 2:1988;72.
2. Wang P., Chaudry I. H. Mechanism of hepatocellular dysfunction during hyperdynamic sepsis. Am. J. Physiol. 270:1996;R927.
3. Cybulsky M. I., Chan M. K., Movat H. Z. Acute inflammation and microthrombosis induced by endotoxin, interleukin-1 and tumor necrosis factor and their implication in gram-negative infection. Lab. Invest. 58:1988;365.
4. Ishiki Y., Ohnishi H., Muto Y., Matsumoto K., Nakamura T. Direct evidence that hepatocyte growth factor is a hepatotrophic factor for liver regeneration and has a potent anti hepatitis effect in vivo. Hepatology. 16:1992;1227.
5. Matsumoto K., Hashimoto K., Yashikawa K., Nakamura T. Marked stimulation of growth and motility of human keratinocytes by hepatocyte growth factor. Exp. Cell. Res. 196:1991;114.
6. Montesano R., Schaller G., Orci L. Induction of epithelial tubular morphogenesis in vitro by fibroblast-derived soluble factors. Cell. 66:1991;697.
7. Higashio K., Shima N., Goto M., Itagaki Y., Nagao M., Yasuda H., Morinaga T. Identity of a tumor cytotoxic factor from human fibroblasts and hepatocyte growth factor. Biochem. Biophys. Res. Commun. 170:1990;397.
8. Shima N., Tsuda E., Goto M., Yano K., Hayasaka H., Ueda M., Higashio K. Hepatocyte growth factor and its variant with a deletion of five amino acids are distinguishable in their biological activity and tertiary structure. Biochem. Biophys. Res. Commun. 200:1994;808.
9. Masunaga H., Fujise N., Shiota A., Yamashita Y., Yasuda H., Higashio K. Amelioration of disordered hepatic protein synthesis by the deleted form of hepatocyte growth factor in models of liver failure in rats. J. Pharm. Pharmacol. 48:1996;876.
10. Masunaga H., Fujise N., Shiota A., Ogawa H., Sato Y., Imai E., Yasuda H., Higashio K. Preventive effects of the deleted form of hepatocyte growth factor against various liver injuries. Eur. J. Pharmacol. 342:1998;267.
11. Miller S. B., Martin D. R., Kissane J., Hammerman M. R. Hepatocyte growth factor accelerates recovery from acute ischemic renal injury in rats. Am. J. Physiol. 266:1994;F129.
12. Mizuno S., Kurosawa T., Matsumoto K., Mizuno Y., Okamoto M., Nakamura T. Hepatocyte growth factor prevents renal fibrosis and dysfunction in a mouse model of chronic renal disease. J. Clin. Invest. 101:1998;1827.
13. Yanagita K., Matsumoto K., Sekiguchi K., Ishibashi H., Niho Y., Nakamura T. Hepatocyte growth factor may act as a pulmotrophic factor on lung regeneration after acute lung injury. J. Biol. Chem. 268:1993;21212.
14. Ohmichi H., Matsumoto K., Nakamura T. In vivo mitogenic action of HGF on lung epithelial cells: Pulmotrophic role in lung regeneration. Am. J. Physiol. 270:1996;L1031.
15. Sakon M., Kita Y., Yoshida T., Umeshita K., Gotoh M., Kanai T., Kawasaki T., Kambayashi J., Monden M. Plasma hepatocyte growth factor levels are increased in systemic inflammatory response syndrome. Surg. Today. 26:1996;236.
16. Shiota G., Umeki K., Okano J., Kawasaki H. Hepatocyte growth factor and acute phase proteins in patients with chronic liver disease. J. Med. 26:1995;295.
17. Ueda T., Takeyama Y., Hori Y., Nishikawa J., Yamamoto M., Saitoh Y. Hepatocyte growth factor in assessment of acute pancreatitis: Comparison with C-reactive protein and interleukin-6. J. Gastroenterol. 32:1997;63.
18. Wichterman K. A., Baue A. E., Chaudry I. H. Sepsis and septic shock - A review of laboratory models and a proposal. J. Surg. Res. 29:1980;189.
19. Ejiri S., Eguchi Y., Kishida A., Xie G., Kurumi Y., Kodama M. Protective effect of prostaglandin 12 analogue on grafted livers subjected to in situ warm ischemia in porcine orthotopic liver transplantation: Immunohistochemical analysis of thrombomodulin. Transplant. Proc. 28:1996;1086.
20. Dittman W. A., Majerus P. W. Structure and function of thrombomodulin: A natural anticoagulant. Blood. 75:1990;329.
21. Esmon C. T. The roles of protein C and thrombomodulin in the regulation of blood coagulation. J. Biol. Chem. 264:1989;4743.
22. Fajardo L. F. The complexity of endothelial cells. Am. J. Clin. Pathol. 92:1989;241.
23. Cross A. S., Opal S. M., Sadoff J. C., Gemski P. Choice of bacteria in animal models of sepsis. Infect. Immun. 61:1993;2741.
24. Webber E. M., Godowski P. J., Fausto N. In vivo response of hepatocytes to growth factors requires an initial priming stimulus. Hepatology. 19:1994;489.
25. Fausto N., Webber E. M. Control of liver growth. Crit. Rev. Eukaryotic Gene Expression. 3:1993;117.
26. Lentz S. R., Tsiang M., Sadler J. E. Regulation of thrombomodulin by tumor necrosis factor-α: Comparison of transcriptional and posttranscriptional mechanisms. Blood. 77:1991;542.
27. Moore K. L., Andreoli S. P., Esmon N. L., Esmon C. T., Bang N. U. Endotoxin enhances tissue factor and suppresses thrombomodulin expression of human vascular endothelium in vitro. J. Clin. Invest. 79:1987;124.
28. Vincent J. L., Van Der Linden P. Septic shock: Particular type of acute circulatory failure. Crit. Care Med. 18:1990;S70.
29. Bakker J., Coffernils M., Leon M., Gris P., Vincent J. L. Blood lactate levels are superior to oxygen-derived variables in predicting outcome in human septic shock. Chest. 99:1991;956.